Oncology and Hematology

Episodes 177-192 of 463

Nanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Nanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Project Oncology®
Nanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Collaborative Insights to Solve the Puzzle of Bladder Cancer
Collaborative Insights to Solve the Puzzle of Bladder Cancer
CME/CE
Collaborative Insights to Solve the Puzzle of Bladder Cancer
1.00 credit
- Daniel P. Petrylak, MD
- Elizabeth R. Plimack, MD, MS, FASCO
- Evan Y. Yu, MD
1.00 credit
Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care
Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care
Project Oncology®
Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care
- Shaji K. Kumar, MD
The Impact of a Plant-Based Diet on Multiple Myeloma Prevention and Progression
The Impact of a Plant-Based Diet on Multiple Myeloma Prevention and Progression
Project Oncology®
The Impact of a Plant-Based Diet on Multiple Myeloma Prevention and Progression
- Urvi A. Shah, MD, MS
Patient Perspectives on Bladder Cancer
Patient Perspectives on Bladder Cancer
MinuteCE®
Patient Perspectives on Bladder Cancer
0.50 program credits
- Elizabeth R. Plimack, MD, MS, FASCO
- Lillibeth Velasco, MSN, RN
0.50 program credits
MinuteCE®
Understanding the Expanding Role of Antibody-Drug Conjugates in Bladder Cancer
0.50 credits 3 episodes
- Elizabeth R. Plimack, MD, MS, FASCO
- Lillibeth Velasco, MSN, RN
0.50 credits 3 episodes
Reviewing the Latest Bladder Cancer Practice Guidelines
Reviewing the Latest Bladder Cancer Practice Guidelines
MinuteCE®
Reviewing the Latest Bladder Cancer Practice Guidelines
0.50 program credits
- Elizabeth R. Plimack, MD, MS, FASCO
0.50 program credits
Exploring New and Emerging Treatments in Muscle Invasive Bladder Cancer
Exploring New and Emerging Treatments in Muscle Invasive Bladder Cancer
MinuteCE®
Exploring New and Emerging Treatments in Muscle Invasive Bladder Cancer
0.50 program credits
- Elizabeth R. Plimack, MD, MS, FASCO
0.50 program credits
Establishing D-VRd Efficacy for Transplant-Ineligible Multiple Myeloma
Establishing D-VRd Efficacy for Transplant-Ineligible Multiple Myeloma
Project Oncology®
Establishing D-VRd Efficacy for Transplant-Ineligible Multiple Myeloma
Prostate Cancer: Lifestyle Recommendations During Androgen Deprivation Therapy
Prostate Cancer: Lifestyle Recommendations During Androgen Deprivation Therapy
Global Oncology Academy
Prostate Cancer: Lifestyle Recommendations During Androgen Deprivation Therapy
- Tanya Dorff, MD
Patient-Centered Insights for Advanced Prostate Cancer Treatment
Patient-Centered Insights for Advanced Prostate Cancer Treatment
Global Oncology Academy
Patient-Centered Insights for Advanced Prostate Cancer Treatment
- Tanya Dorff, MD
Maximizing Myeloma Outcomes With GPRC5D-Directed Therapy: Practical Expert Case Studies and Best Practices
Maximizing Myeloma Outcomes With GPRC5D-Directed Therapy: Practical Expert Case Studies and Best Practices
CME/CE
Maximizing Myeloma Outcomes With GPRC5D-Directed Therapy: Practical Expert Case Studies and Best Practices
0.25 credits
0.25 credits
Exercise in Multiple Myeloma: Balancing Benefits and Safety
Exercise in Multiple Myeloma: Balancing Benefits and Safety
Project Oncology®
Exercise in Multiple Myeloma: Balancing Benefits and Safety
- Jens Hillengass, MD, PhD
Molecular Profiling for HER2+ Advanced Solid Tumors
Molecular Profiling for HER2+ Advanced Solid Tumors
CME/CE
Molecular Profiling for HER2+ Advanced Solid Tumors
1.00 credit
- Eric Van Cutsem, MD, PhD
- David SP Tan, MBBS, PhD, PRCP
- James Chih-Hsin Yang, MD, PhD
- Kathleen Moore, MD, MS, FASCO
1.00 credit
Advances in Prostate Cancer Care: Genetic Testing, Teamwork, and ARPIs
Advances in Prostate Cancer Care: Genetic Testing, Teamwork, and ARPIs
Global Oncology Academy
Advances in Prostate Cancer Care: Genetic Testing, Teamwork, and ARPIs
- Neal Shore, MD, FACS
mCRPC Care: Predicting Outcomes with a Novel Cell-Free DNA Sequencing Assay
mCRPC Care: Predicting Outcomes with a Novel Cell-Free DNA Sequencing Assay
Global Oncology Academy
mCRPC Care: Predicting Outcomes with a Novel Cell-Free DNA Sequencing Assay
- Scott Dehm, PhD